This is the authors' abstract. We don't add key points for this paper.
Nonsurgical treatment options are increasingly needed for endometrial atypical hyperplasia (AH) and endometrioid endometrial cancer (EEC). Despite promising initial response rates, prospective long-term data and determinants for relapse are limited.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bowen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: